Pediatrix Medical Group, Inc.
MDNYSEHealthcare● Active
$22.47
$-0.14(-0.62%)
Market Cap$1.8B
P/E Ratio—
52W High$24.99
52W Low$11.84
Pediatrix Medical Group, Inc. (MD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MD · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B |
| Cost of Revenue | $1.44B | $1.56B | $1.57B | $1.50B | $1.40B |
| Gross Profit | $0.47B | $0.45B | $0.42B | $0.47B | $0.51B |
| Gross Margin %(computed) | 24.66% | 22.57% | 21.13% | 23.68% | 26.85% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.24B | $0.24B | $0.23B | $0.23B | $0.26B |
| Total Operating Expenses | $0.24B | $0.52B | $0.41B | $0.29B | $0.31B |
| Operating Income | $0.23B | ($0.07B) | $0.01B | $0.17B | $0.20B |
| Operating Margin %(computed) | 12.07% | -3.41% | 0.37% | 8.76% | 10.62% |
| Interest Income | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.04B | $0.04B | $0.04B | $0.04B | $0.07B |
| Income Before Tax | $0.22B | ($0.10B) | ($0.05B) | $0.08B | $0.14B |
| Income Tax Expense | $0.05B | ($0.00B) | $0.01B | $0.02B | $0.03B |
| Net Income | $0.17B | ($0.10B) | ($0.06B) | $0.07B | $0.13B |
| Net Margin %(computed) | 8.64% | -4.92% | -3.03% | 3.36% | 6.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.94 | $-1.19 | $-0.72 | $0.80 | $1.52 |
| Wtd Avg Shares | 0.09B | 0.08B | 0.08B | 0.08B | 0.09B |
| EBITDA | $0.27B | ($0.03B) | $0.03B | $0.16B | $0.24B |
| EBITDA Margin %(computed) | 14.33% | -1.41% | 1.50% | 7.95% | 12.35% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Pediatrix Medical Group, Inc. data
About Pediatrix Medical Group, Inc. (MD) Income Statement
Pediatrix Medical Group, Inc. (MD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MD reported revenue of $1.91B, gross profit of $0.47B (gross margin 24.66%), and net income of $0.17B — a net profit margin of 8.64%.
Frequently asked questions
MD · 4 questionsPediatrix Medical Group, Inc. (MD) reported revenue of $1.91B for 2025, down 4.9% year-over-year.
MD revenueMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08